Action Avanir - AVN

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Dernier

Prix Achat

Prix Vente

Volume échangé

0,00 Fourchette du Jour 0,00

0,00 Plage de 52 semaines 0,00

Clôture Veille

Ouverture

Dernière Transaction

Dernière heure de transaction

Volume moyen (3 m)

Volume financier

VWAP

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

Avanti Communications Group Plc 21 December 2009 ? Date: 21 December 2009 On behalf of: Avanti Communications Group plc ("Avanti", "the Group...

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

NEW YORK, Aug. 29 /PRNewswire/ -- The American Stock Exchange(R) (Amex(R)) opened trading today on Merrill Lynch's 12% Callable STRIDES Linked...

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

IRVINE, Calif., Feb. 1 /PRNewswire-FirstCall/ -- Cobalis Corp. (OTC:CLSC) (BULLETIN BOARD: CLSC) , a pharmaceutical development company...

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

The previously announced one-for-four reverse split by AVANIR Pharmaceuticals (AMEX:AVN) of its common stock has become effective, with post-split...

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals (AMEX:AVN) announced today that it has signed an exclusive agreement with a leading importer and distributor of...

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR Pharmaceuticals (AMEX:AVN) announced today that Randall E. Kaye, M.D. has joined the company in the newly created role of Vice President of...

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals (AMEX: AVN) announced today that its Board of Directors has approved the implementation of a one-for-four reverse split of...

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

AVANIR Pharmaceuticals (AMEX:AVN) will be presenting at the 24th Annual JPMorgan Healthcare Conference on Wednesday, January 11, 2005, at 4:00...

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals (AMEX:AVN) announced today that a Phase I study has been initiated in partnership with AstraZeneca UK Limited (AstraZeneca...

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVANIR Pharmaceuticals (AMEX: AVN) announced today that its presentation at the Lazard Capital Markets Annual Life Sciences Conference in New...

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

AVN - Frequently Asked Questions (FAQ)

What is the current Avanir share price?

The current share price of Avanir is US$ 0,00

What is the 1 year trading range for Avanir share price?

Avanir has traded in the range of US$ 0,00 to US$ 0,00 during the past year

Volume
% Gagnants
% Perdants

Symbole	Prix	Vol.
LFAWStone Ridge 2060 Longevity Income ETF	US$ 169,74 (910,16%)	100
LIAUStone Ridge 2060 Inflation-Protected Longevity Income ETF	US$ 241,157 (900,00%)	1
LIAWStone Ridge 2062 Inflation-Protected Longevity Income ETF	US$ 254,313 (900,00%)	2
LIAVStone Ridge 2061 Inflation-Protected Longevity Income ETF	US$ 247,646 (900,00%)	6
ROBNT Rex 2X Long HOOD Daily Target ETF	US$ 33,87 (23,66%)	452,92k
BURUNuburu Inc	US$ 0,2184 (-12,99%)	1,02M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2,895 (-10,09%)	20,22M
KOLDProShares UltraShort Bloomberg Natural Gas	US$ 25,8001 (-9,73%)	5,72M
AEONAEON Biopharma Inc	US$ 0,1236 (-9,12%)	2,24M
RYDERyde Group Ltd	US$ 0,3186 (-8,71%)	160,51k
SOXLDirexion Daily Semiconductor Bull 3X Shares	US$ 28,19 (2,36%)	27,2M
TSLZT Rex 2X Inverse Tesla Daily Target ETF	US$ 2,895 (-10,09%)	20,22M
SOXSDirexion Daily Semiconductor Bear 3X Shares New	US$ 19,5356 (-2,47%)	17,75M
DNNDenison Mines Corp	US$ 1,745 (-0,85%)	17,09M
AZTRAzitra Inc	US$ 0,3671 (14,36%)	16,79M

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

12% Strides Linked TO Apple, Inc. (AVN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

AVN Dernières nouvelles

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

12% Strides Linked TO Apple, Inc. (AVN) Cours

12% Strides Linked TO Apple, Inc. (AVN)

Votre Hub pour des idées et discussions en direct en temps réel

Statistiques et détails clés

AVN Dernières nouvelles

Avanti Comms Group 86m Placing & 194m Debt for 2nd Satellite Launch

American Stock Exchange Lists Merrill Lynch's 12% Callable STRIDES Linked To Apple, Inc.

Dr. Gerald Yakatan, Former President and CEO of Avanir Pharmaceuticals, Joins Cobalis Corp. Board of Directors

AVANIR Implements One-for-Four Reverse Stock Split and New Stock Ticker Symbol

AVANIR Licenses Docosanol 10% Cream in Japan

AVANIR Pharmaceuticals Hires Randall E. Kaye, M.D. as Vice President of Medical Affairs

AVANIR's Board of Directors Approves the Implementation of a One-for-Four Reverse Stock Split

AVANIR Pharmaceuticals Invites Investors to the 24th Annual JPMorgan Healthcare Conference Webcast

Phase I Reverse Cholesterol Transport Trial Initiated; AVANIR to Receive $5 Million Milestone

AVANIR Pharmaceuticals Invites Investors to the Lazard Capital Markets Life Sciences Conference Webcast

AVN - Frequently Asked Questions (FAQ)

Moteurs

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités

Période	Variation	Variation %	Ouver.	Haut	Bas	Moyenne Vol. Quot.	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE